Hepatitis Viruses Flashcards

1
Q

What is hepatitis?

A
  • The wound-healing response of the liver to many causes of chronic injury.
  • Various risk factors can lead to inflammation of the liver (hepatitis).
  • This can be either self-limiting or can progress to chronic fibrosis (scarring).
  • Most types of liver insult damage epithelial cells which causes release of inflammatory mediators. This is the main cause of fibrosis in liver injury.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is viral hepatitis?

What are the causes?

A
  • Viral infection of the liver which causes hepatitis.
  • Causes:
    • Viral hepatitis viruses (hepatitis A, B, C, D, E, F and G).
    • Cytomegalovirus
    • Epstein-Barr virus
    • Herpes viruses (mostly in immunocompromised patients)
    • Others (yellow fever virus, dengue virus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the natural history of liver damage.

A
  • Fibrosis normally does not cause much of a problem.
  • It becomes clinically relevant and important when dysregulation and excessive scarring occurs in response to persistent injury.
  • This leads to tissue dysfunction.
  • There is a backward resolution and regression of fibrosis; this is when the underlying cause is eliminated.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Discuss the global disease burden of viral hepatitis.

A
  • ~1.5 million deaths per year (death toll comparable to that of HIV, TB and malaria).
  • Estimated that 240 million people live with chronic hepatitis B.
  • Estimated that 150 million people live with chronic hepatitis C.
  • Hepatitis B and C are distributed worldwide, but Africa and Asia have the highest prevalence.
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the clinical features of most viral hepatitisis?

A
  • Prodromal symptoms are generally systemic and variable.
  • Constitutional symptoms may precede symptoms and signs of liver disease:
    • Anorexia
    • Flu-like symptoms
    • Fatigue
    • Malaise
    • Myalgia
    • Headache
    • Low-grade fever
  • Liver dysfunction:
    • Jaundice
    • Dark urine
    • Abdominal pain
    • Enlarged and tender liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is the diagnosis of viral hepatitis made?

A
  • Most diagnoses can be made with careful history taking:
    • Clinical details
    • Incubation period
    • Epidemiological risk factors
      • Travel
      • Drug use
      • Unprotected sex
    • Vaccination history
    • Examination and LFT pattern
      • Can tell if acute or chronic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CASE STUDY 1

  • 30 year old male
  • Returning traveller from Thailand
  • Presents to GP with abdominal pain
  • Generally not feeling well (last 2-3 days)
  • Girlfriend has noticed that eyes have become yellow

What are the initial differential diagnoses?

What do you need to obtain from the history?

A
  • Differentials
    • Hepatitis A
      • Patient travelled to high endemic area
    • Hepatitis B
      • Don’t know patient’s risk factors
    • Hepatitis C
    • Cholangitis / cholecystitis
    • Medication / other drugs
    • Other infections that could cause abdominal pain (typhoid / dengue)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CASE STUDY 1 Continued

  • Blood results:
    • ALT 1000 (normal range <40)
    • Bilirubin 65 (normal range <12)
    • INR 2.5 (normal range <1)
    • Albumin 34 (normal range >35)
    • Lactate 1.5 (normal range <1)
  • Confirms no use of recreational drugs.
  • After previous denial, now admits to unprotected sex (heterosexual) 1 month into his travels (~3 months ago).

Now what are the differentials?

A
  • Hepatitis A incubation period ~28 days (15-50 days). Can rule out.
  • Hepatitis B incubation period ~3 months - stratify risk.
  • Hepatitis C incubation period ~45 days - stratify risk.
  • Hepatitis E incubation period ~40 days (but generally present much earlier (15-60 days). Patient has been in an endemic area. Can rule out.
  • Cholangitis - unlikely given that he did not present with fever. Can rule out.
  • Drugs - denies use but cannot rule out.
  • Other infections that could cause abdominal pain (typhoid, dengue) - no history of fever so not likely. Can rule out.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the incubation period of HBV?

How is it transmitted?

What percentage of babies and children under 6 become chronically infected?

A
  • Incubation period - up to 6 months.
  • Infection becomes chronic in 5% of patients.
  • 90% of babies and 30-50% of children under the age of 6 will develop chronic infection.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the incubation period of HCV?

How is it transmitted?

What percentage of patients spontaneously clear the infection?

What percentage of patients become chronically infected?

A
  • Incubation period - up to 6 months, but most patients present after ~45 days.
  • Approximately 30% spontaneously clear the infection.
  • 70% become chronically infected.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CASE STUDY 1

What is the top differential?

A
  • Top differential is HVB.
  • Still need to exclude HCV and HIV (returning traveller, unprotected sex).
  • Given that he presented with very high LFTs - suggests acute infection.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the viral serology tests which can be carried out for HBV?

A
  • HBV surface antigen (HBsAg) - active or current infection.
  • HBV anti-surface antibody (Anti-HBsAb) - vaccine / natural immunisation.
  • HBV core IgG antibody (IgG Anti-HBcAb) - chronic HBV or past infection.
  • HBV core IgM antibody (IgM Anti-HbcAb) - diagnostic for acute infection
  • HBV e antigen / antibody (HBeAg/Ab)
  • HBV DNA (PCR) - not a screening test.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the viral serology tests which can be carried out for HCV?

A
  • Anti-HCV antibody - past or chronic infection
  • HCV antigen - active / current infection
  • HCV RNA (PCR) - not a screening test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the management of acute HBV.

A
  • Acute hepatitis B does not usually require specific treatment, but may require treatment to relieve the symptoms.
  • Likely to will spontaneously clear HBV.
  • No need to carry out HBV DNA as it will certainly be high; not useful.
  • Repeat bloods in 3-4 weeks to ensure he develops antibodies.
  • Advise to use protection.
  • Vaccination of household contacts and partner.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the properties of chronic HBV infection.

What follow-up do these patients need?

A
  • HBsAg positive > 6 months.
  • IgG anti-HBc - positive.
  • Anti-HBsAg - negative.
  • HDV caused superinfection with HBV.
  • Referral to an infectious diseases specialist or gastroenterologist is required.
  • These patients will require regular (minimum 6 monthly) LFTs, HBV markers and fibroscan due to increased risk of HCC, and some patients require treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the management of chronic HBV.

Outline the current treatment options.

A
  • The goal of treatment is to improve survival and quality of life by preventing disease progression, and consequently HCC development.
  • Current treatment options are:
    • Pegylated interferon (PegIFNa): subcutaneous for 48 weeks.
    • Nucleos(t)ide analogue (NA) therapy: oral treatment, long-term until HBsAg loss.
      • Iamivudine (LAM), adefovir dipivoxil (ADV), entecavir (ETV), telbivudine (TBV), tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF).
17
Q

What is meant by ‘functional cure’ of HBV?

A

The loss of HBsAg is regarded as the optimal treatment end-point and is termed ‘functional cure’.

18
Q

What are the goals of treatment of chronic HCV?

A
  • Prevent the complications of HCV-related liver and extra-hepatic diseases, including hepatic necroinflammation, fibrosis, cirrhosis, decompensation of cirrhosis, HCC, severe extra-hepatic manifestations and death.
  • Improve quality of life and remove stigma.
  • Prevent onward transmission of HCV.
19
Q

Describe the management of chronic HCV.

A
  • Current treatment includes oral direct acting antivirals achieving sustained virological response / clearance (cure).
  • Current treatment has >95% efficacy.
20
Q

Describe the aetiology of hepatitis A.

A
  • Transmission - faecal-oral route.
  • Person-to-person contact, or contaminated food or drink.
  • Foodborne outbreaks have been reported following ingestion of certain shellfish (mussels, oysters and clams that feed by filtering large volumes of sewage-polluted waters) and salad vegetables.
21
Q

How does hepatitis A infection present in most children?

And in most adults?

A
  • Asymptomatic disease is common in children; jaundice may occur in 70-80% of those infected as adults.
  • Causes acute infection. Does not cause chronic infection.
22
Q

What are the risk factors for HAV related outbreaks?

A
  • Among MSM
  • IVDU
  • Consumption of contaminated frozen berries
23
Q

Describe the aetiology of hepatitis E.

A
  • Transmission: feacal-oral route.
  • Can also become infected from contaminated drinking water, uncooked / undercooked pork or deer meat, person-to-person transmission, contaminated blood / organ.
  • Endemic to EU/EEA countries.
24
Q

Describe how hepatitis E presents.

A
  • Infection may be asymptomatic or cause an acute self-limiting hepatitis.
  • HEV infection can also cause extrahepatic manifestations, neurological, renal and haematological disorders.
  • Persistent chronic HEV infection has been reported particularly among those who are immunosuppressed or who have pre-existing liver disease.
25
Q

What are the available tests for HAV and what do they tell you?

A
  • Anti-HAV IgM - recent infection.
  • Anti-HAV IgG - past infection / vaccination.
  • HAV RNA (PCR) - not widely available, not a screening test.
26
Q

What are the available tests for HEV and what do they tell you?

A
  • Anti-HEV IgM - recent infection.
  • HEV RNA (PCR) - not a screening test.
27
Q

Describe the management of acute HAV.

A
  • Advice on good hygiene practice.
  • Exclude from work until 7 days post-onset of jaundice or in absence of jaundice, from the onset of compatible symptoms.
  • Identify possible source of infection.
  • Undertake risk assessment.
  • Infectious period is taken from 2 weeks before the onset of first symptoms and until one week after the onset of jaundice.
  • Management of close contacts.
  • Inform public health.